Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Calcipotriene, Clobetasol, and Tacrolimus for Pediatric Morphea
NCT02680717Phase 1Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- Mar 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of calcipotriol, clobetasol and Tacrolimus Ointment 0.1% Iwaki in localized scleroderma (3 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Visual Analog Scale at 4 months. Planned start Mar 2016; status: withdrawn.
02
Drugs
calcipotriolclobetasolTacrolimus Ointment 0.1% Iwaki
03
Conditions
localized scleroderma
Beyond the preview
Go deeper on NCT02680717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680717.